4WK Stock Overview
Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People’s Republic of China.
Wenzhou Kangning Hospital Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$1.38|
|52 Week High||HK$5.60|
|52 Week Low||HK$0.83|
|1 Month Change||3.76%|
|3 Month Change||21.05%|
|1 Year Change||-50.71%|
|3 Year Change||-70.94%|
|5 Year Change||-65.83%|
|Change since IPO||-74.58%|
Recent News & Updates
|4WK||DE Healthcare||DE Market|
Return vs Industry: 4WK underperformed the German Healthcare industry which returned -19.8% over the past year.
Return vs Market: 4WK underperformed the German Market which returned -12.4% over the past year.
|4WK Average Weekly Movement||10.8%|
|Healthcare Industry Average Movement||5.2%|
|Market Average Movement||6.4%|
|10% most volatile stocks in DE Market||10.8%|
|10% least volatile stocks in DE Market||3.5%|
Stable Share Price: 4WK is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: 4WK's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People’s Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services.
Wenzhou Kangning Hospital Fundamentals Summary
|4WK fundamental statistics|
Is 4WK overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4WK income statement (TTM)|
|Cost of Revenue||CN¥845.31m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||1.06|
|Net Profit Margin||6.43%|
How did 4WK perform over the long term?See historical performance and comparison
Is Wenzhou Kangning Hospital undervalued compared to its fair value and its price relative to the market?
Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 4WK (€1.38) is trading below our estimate of fair value (€7.51)
Significantly Below Fair Value: 4WK is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 4WK is good value based on its PE Ratio (9.8x) compared to the German Healthcare industry average (19x).
PE vs Market: 4WK is good value based on its PE Ratio (9.8x) compared to the German market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: 4WK is good value based on its PEG Ratio (0.6x)
Price to Book Ratio
PB vs Industry: 4WK is good value based on its PB Ratio (0.6x) compared to the DE Healthcare industry average (1.3x).
How is Wenzhou Kangning Hospital forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4WK's forecast earnings growth (17% per year) is above the savings rate (-0.05%).
Earnings vs Market: 4WK's earnings (17% per year) are forecast to grow faster than the German market (7.8% per year).
High Growth Earnings: 4WK's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4WK's revenue (12.6% per year) is forecast to grow faster than the German market (4.9% per year).
High Growth Revenue: 4WK's revenue (12.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4WK's Return on Equity is forecast to be low in 3 years time (7.7%).
How has Wenzhou Kangning Hospital performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4WK has high quality earnings.
Growing Profit Margin: 4WK's current net profit margins (6.4%) are higher than last year (4.4%).
Past Earnings Growth Analysis
Earnings Trend: 4WK's earnings have grown by 1.6% per year over the past 5 years.
Accelerating Growth: 4WK's earnings growth over the past year (83.7%) exceeds its 5-year average (1.6% per year).
Earnings vs Industry: 4WK earnings growth over the past year (83.7%) exceeded the Healthcare industry 55.1%.
Return on Equity
High ROE: 4WK's Return on Equity (5.2%) is considered low.
How is Wenzhou Kangning Hospital's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4WK's short term assets (CN¥783.8M) exceed its short term liabilities (CN¥554.2M).
Long Term Liabilities: 4WK's short term assets (CN¥783.8M) exceed its long term liabilities (CN¥484.6M).
Debt to Equity History and Analysis
Debt Level: 4WK's net debt to equity ratio (18.5%) is considered satisfactory.
Reducing Debt: 4WK's debt to equity ratio has increased from 7.3% to 41.1% over the past 5 years.
Debt Coverage: 4WK's debt is well covered by operating cash flow (38.8%).
Interest Coverage: 4WK's interest payments on its debt are well covered by EBIT (6.7x coverage).
What is Wenzhou Kangning Hospital current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 4WK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 4WK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 4WK's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 4WK's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: 4WK is not paying a notable dividend for the German market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 4WK has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Lianyue Wang (52 yo)
Ms. Lianyue Wang serves as General Manager at Wenzhou Kangning Hospital Co., Ltd. Since September 2011, and has been its Executive Director since September 22, 2014 were she is primarily responsible for th...
CEO Compensation Analysis
Compensation vs Market: Lianyue's total compensation ($USD71.73K) is below average for companies of similar size in the German market ($USD390.84K).
Compensation vs Earnings: Lianyue's compensation has been consistent with company performance over the past year.
Experienced Management: 4WK's management team is seasoned and experienced (7.7 years average tenure).
Experienced Board: 4WK's board of directors are considered experienced (4.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Wenzhou Kangning Hospital Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Wenzhou Kangning Hospital Co., Ltd.
- Ticker: 4WK
- Exchange: DB
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: HK$872.898m
- Listing Market Cap: HK$105.574m
- Shares outstanding: 72.14m
- Website: https://www.knhosp.cn
Number of Employees
- Wenzhou Kangning Hospital Co., Ltd.
- No.1 Shengjin Road
- Huanglong Residential District
- Zhejiang Province
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/17 00:00|
|End of Day Share Price||2022/05/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.